利柏特(605167.SH):簽訂15至20億元的巴斯夫相關EPC工程總承包項目
格隆匯7月31日丨利柏特(605167.SH)公佈,公司全資子公司上海利柏特工程技術有限公司於2022年7月29日與巴斯夫一體化基地(廣東)有限公司簽訂了《巴斯夫(廣東)一體化項目中央罐區化學品罐區和裝車站工程設計、採購、施工總承包合同》,合同金額人民幣15至20億元(因業主商業信息保密要求)。
該項目的承接是中國化工領域的重要外商投資企業對利柏特設計、管理、製造、採購、施工全產業鏈整體實力認可的體現,將有助於鞏固公司的市場地位,對公司未來進一步開拓華南市場具有里程碑意義;
該項目是公司首次以EPC工程總承包方式承接的巴斯夫項目,也是近年來公司所承接單體規模最大的項目。通過項目的履行,公司將進一步提升超大型項目全過程管理能力並將智能化製造管理理念貫穿項目全過程,包括項目的數字化移交工作等,對推動相關行業的智能化管理有積極影響;
該項目是湛江利柏特模塊製造有限公司一期成功交付後,公司所簽訂的華南區域首個重大項目,可以有效利用公司湛江生產基地的區位優勢,對募投項目發揮產能有積極的作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.